Precision treatment for rare tumors guided by lab tests
Treatments studied
Part of Cancer clinical trials.
This trial tests a personalized approach for people with rare advanced or metastatic solid tumors. Doctors use special lab tests on your tumor tissue and blood to find the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a rare solid tumor that has spread or cannot be removed by surgery.
- You are generally able to care for yourself (ECOG score 0 or 1).
- You have at least one tumor that can be measured on a scan.
- You can provide a fresh tissue sample (biopsy) or a large fluid sample for testing.
- You have had no other cancer treatment before providing this sample.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests targeted drugs or immunotherapy based on the genetic features of your tumor. It may help people with rare, advanced cancers whose disease has progressed after standard treatment options.
This trial tests new experimental cancer treatments and technologies for people with rare or hard-to-treat tumors. It aims to find tailored therapies that may work better for your specific cancer. You will be asked to provide a tumor sample for testing, and the trial team will guide you through the process.
This trial uses genetic testing of your tumor to match you with a targeted therapy. It is for people with advanced solid tumors who have exhausted or cannot tolerate standard treatments.
This trial compares treatment based on a detailed analysis of your tumor's genes (genome and transcriptome) with standard care. It aims to find better treatment options for people with advanced rare cancers that have not responded to previous therapy.
This trial tests whether using a precise medicine based on your tumor's unique biomarker can help treat rare cancers more effectively. It aims to offer personalized therapy when standard options are limited.
This trial studies whether giving a targeted cancer medicine based on tumor genetic/protein test results can help people with advanced, incurable cancers live longer. You may be eligible if your cancer has a “potentially actionable” change on testing and you meet health and follow-up requirements.
Hear when a new Rare Tumour trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.